Featured Research

from universities, journals, and other organizations

Protein link may be key to new treatment for aggressive brain tumor

Date:
January 1, 2010
Source:
University of Central Florida
Summary:
Biomedical researchers have found a protein that could hold the key to treating one of the most common and aggressive brain tumors in adults. Glioblastoma multiforme, the type of malignant brain tumor that killed the late US Sen. Edward Kennedy, is difficult to treat because it spreads cancerous cells to other parts of the brain very quickly. About 10,000 cases are diagnosed in the United States each year.

Biomedical researchers at the University of Central Florida have found a protein that could hold the key to treating one of the most common and aggressive brain tumors in adults.
Credit: Jacque Brund

Biomedical researchers at the University of Central Florida have found a protein that could hold the key to treating one of the most common and aggressive brain tumors in adults.

Related Articles


Glioblastoma multiforme (GBM), the type of malignant brain tumor that killed the late U.S. Sen. Edward Kennedy, is difficult to treat because it spreads cancerous cells to other parts of the brain very quickly. About 10,000 cases are diagnosed in the United States each year.

There is no cure, and treatments have limited success. They consist of surgically removing the tumor from the brain, followed by radiation therapy and chemotherapy. About half of the patients don't survive for more than a year after their diagnosis

That's why the role of the protein TRPC6 discovered at UCF is so promising.

"Collectively, our studies indicate that TRPC6 is a key mediator of tumor growth of GBM. It may be a promising therapeutic target in the treatment of human GBM," said Sic L. Chan, the UCF assistant professor of Neuroscience who led the team of scientists.

TRPC6 is a receptor channel protein found in most, if not all, cells in the body. It promotes cell growth during development of the central nervous system.

Chan and his team ran several experiments with cancerous brain tissue obtained from Florida Hospital in Orlando and Duke University Medical Center. They found that this protein is strongly expressed and functional in brain tumor cells. Further research found that they could stop the growth and spread of tumors by knocking down the expression of this protein.

It is the first time such findings have been made with this particular kind of brain tumor.

"This is very exciting, because our work will help patients in the future," said UCF research fellow Srinivasulu Chigurupati, who worked on the team. "Malignant gliomas remain one of the most devastating cancers despite recent advancements."

UCF's research findings are published in the Jan. 1, 2010, edition of the journal Cancer Research.

Others who contributed to the research include Raji Venkataraman, Daniel Barrera, Anusha Naganathan, Meenu Madan, Leena Paul, Jogi V. Pattisapu, George A. Kyriazis and Kiminobu Sugaya from UCF; Sergey Bushnev from Florida Hospital Cancer Institute; and Justin D. Lathia and Jeremy N. Rich from the Duke University Medical Center and the Department of Stem Cell Biology and Regenerative Medicine at the Cleveland Clinic.


Story Source:

The above story is based on materials provided by University of Central Florida. Note: Materials may be edited for content and length.


Cite This Page:

University of Central Florida. "Protein link may be key to new treatment for aggressive brain tumor." ScienceDaily. ScienceDaily, 1 January 2010. <www.sciencedaily.com/releases/2009/12/091222121953.htm>.
University of Central Florida. (2010, January 1). Protein link may be key to new treatment for aggressive brain tumor. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2009/12/091222121953.htm
University of Central Florida. "Protein link may be key to new treatment for aggressive brain tumor." ScienceDaily. www.sciencedaily.com/releases/2009/12/091222121953.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins